People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Pharma, Healthtech, Other, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Advanced Cardiac Therapeutics Inc | — | Pharma | Series C | $64.1M | $1.6B | 2009 |
| Shape Memory Medical Inc. | — | Healthtech | Series B | $61.8M | $22.9M | 2020 |
| Vascular Dynamics, Inc. | — | Other | Series B | $51.4M | $549.1M | 2014 |
| Embrella Cardiovascular Inc | — | Biotechnology | Series A | $6.6M | $54.2M | 2009 |
| Bioabsorbable Therapeutics Inc | — | Other Health Care | Pre-Seed | $360K | $11.1M | 2009 |
Michael Henson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Henson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Thomas Thaler | 2 | 4 |
| Edward F Ruppel, Jr. | 2 | 2 |
| Ryan Drant | 1 | 24 |
| Duke Rohlen | 1 | 10 |
| Doug Koo | 1 | 8 |
| Jeffrey O'Donnell | 1 | 7 |
| Roy Tanaka | 1 | 6 |
| Patrick Rivelli | 1 | 6 |
| Justin Klein | 1 | 6 |
| Robert Stern | 1 | 6 |
| J. Casey McGlynn | 1 | 5 |
| Benjamin Tsai | 1 | 4 |
| Bryan Kim | 1 | 4 |
| Peter Van Der Sluis | 1 | 3 |
| Bruce J Brumfield | 1 | 3 |
| William Olson | 1 | 3 |
| Gregory S. Young | 1 | 3 |
| Allan Johnston | 1 | 3 |
| Maurice Buchbinder | 1 | 3 |
| Renee Masi | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.